🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45719W205 (prev. 45719W106 )
- Market Cap
- Micro Cap
- IPO
- 12/23/2020 · $10.00/share
Business: Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's Disease and related disorders that arise inside and outside of the brain.
Company Contact
- CEO
- Milton H. Werner
- CFO
- Joseph Frattaroli
- Headquarters
- 3350 Riverwood Parkway SE, Suite 1900, Atlanta, GA 30339
- Phone
- 678-392-3419
- Investor Relations
- Milton H. Werner · 678-392-3419 · mhwerner@inhibikase.com